Delivery Order SPE2DB22D3301-SPE2DB25FX3TB
Award Date
10/15/24
Potential Completion Date
10/16/24
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,063.41 firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the delivery of 1 mg vials of the pharmaceutical drug remifentanil, with a completion date of September 6, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts by DLA and other government agencies to supply a wide range of critical medical commodities,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $2,633.40 fixed-price contract is for the supply of Remifentanil 2 mg vials, a specialty pharmaceutical product used in military treatment facilities. The contract has a period of performance through March 22, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of 1 mg vials of the pharmaceutical drug Remifentanil. The $1,063.41 firm fixed price delivery order contract has an ultimate completion date of September 10, 2024. Amerisourcebergen, one of the largest pharmaceutical distributors in the U.S., has been awarded this contract to supply this critical care medication to support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of remifentanil 2 mg vials. The contract has a ceiling value of $5,266.80 and an ultimate completion date of August 8, 2024. The contract is a firm fixed price agreement, with no set-aside designation. AmerisourceBergen, through its extensive federal contracting portfolio, provides a wide range of pharmaceutical...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $5,411.50 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to supply 4,563,552,518 vials of the drug Remifentanil 1 mg. The contract has a completion date of February 6, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of Defense,...
This federal contract award, with ID SPE2DX15D7067|SPE2DX24F2ZVJ, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,649.40 firm fixed-price delivery order is for the supply of 2 mg vials of the pharmaceutical product Remifentanil. The contract has a completion date of July 9, 2024 and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for the supply of 1 mg vials of the pharmaceutical drug remifentanil, with a ceiling value of $4,253.64 and a performance period ending on August 29, 2024. The contract has a firm fixed price pricing structure and does not utilize any set-aside designation. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite...
This is a federal delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $1,149.39, is for the supply of 2 milligram vials of the drug remifentanil. There is no set-aside designation for this contract. AmerisourceBergen, as one of the largest pharmaceutical distributors in the United States, has been awarded numerous federal contracts to provide a wide range of essential medical commodities, including...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,022.40 firm-fixed-price contract is for the supply of 2 mg vials of the drug remifentanil, a potent opioid analgesic. The award has an ultimate completion date of August 5, 2024. Amerisourcebergen holds a larger, up to $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,489.05 contract is for the delivery of Remifentanil 5 mg vials, with a period of performance ending on June 30, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...